The Motley Fool··Jonathan PoncianoMajor Hedge Fund Exits Protagonist Position Despite 120% Stock Surge
BVF Partners liquidated its $170M Protagonist stake despite 120% gains, likely due to changing risk profile as company awaits FDA decision on blood disorder treatment.
PTGXKYMRRVMDRVMDWclinical-stage biotechhedge fund liquidation